Jackson Square Capital, LLC Bausch Health Companies Inc. Transaction History

Jackson Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$7.06 - $23.63 $78,231 - $261,844	-11,081 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$23.0 - $29.01 $171,120 - $215,834	-7,440 Reduced 40.17%	11,081 $306,000
Q3 2021 Oct 21, 2021	BUY	$25.04 - $30.06 $149,989 - $180,059	5,990 Added 47.8%	18,521 $516,000
Q2 2021 Jul 20, 2021	BUY	$27.43 - $32.7 $37,332 - $44,504	1,361 Added 12.18%	12,531 $368,000
Q1 2021 May 18, 2021	BUY	$21.37 - $34.38 $238,702 - $384,024	11,170 New	11,170 $355,000

282

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.62B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.